+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cutaneous Kaposi disease disclosing acquired immunodeficiency syndrome in a child



Cutaneous Kaposi disease disclosing acquired immunodeficiency syndrome in a child



Annales de Dermatologie et de Venereologie 124(4): 318-321



Kaposi's sarcoma associated with acquired immunodeficiency syndrome is uncommon in children and cutaneous localizations are rare. We report a case of pediatric cutaneous Kaposi's sarcoma that revealed a human immunodeficiency virus infection. An 8-years-old girl native of the Ivory Coast, with normal statural and psychomotor development, presented cutaneous Kaposi's sarcoma after varicella. The serodiagnosis was positive for type 1 human immunodeficiency virus and CD4 lymphocytes count was 9/mm3. A tonsil localization of Kaposi's sarcoma occurred and bleomycin was a short time effective. A relapse of cutaneous Kaposi's sarcoma with digestive, pulmonary and neurological symptoms was transitorily controlled by the association prednisone-vinblastine-doxorubicin, but death occurred with recurrence of pharyngeal Kaposi's sarcoma. The review of literature shows that in pediatric acquired immunodeficiency syndrome, failure to thrive, encephalopathy and opportunistic infections are common. On the other hand, Kaposi's sarcoma is unusual and cutaneous localizations are especially observed when the contamination is postnatal and late. In our case the contamination is presumed perinatal and the human immunodeficiency virus infection was asymptomatic until 8 years old. Kaposi's sarcoma was the cause of the most presenting symptoms and of death, without demonstrated opportunistic infections.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 045687609

Download citation: RISBibTeXText

PMID: 9739937


Related references

Cutaneous colesional acquired immunodeficiency syndrome associated Kaposi sarcoma and cryptococcosis. American Journal of Dermatopathology 32(8): 780-786, 2010

Intralesional bleomycin for acquired immunodeficiency syndrome-associated cutaneous Kaposi's sarcoma. Archives of Dermatology 131(2): 228, 1995

Cutaneous acquired immunodeficiency syndrome-associated Kaposi's sarcoma in pediatric patients. Archives of Dermatology 126(6): 791-793, 1990

Cutaneous cryptococcosis simulating Kaposi's sarcoma in the acquired immunodeficiency syndrome. Cutis 45(3): 163-167, 1990

Local therapies for cutaneous Kaposi's sarcoma in patients with acquired immunodeficiency syndrome. Archives of Dermatology 127(10): 1479-1481, 1991

Pulsed-dye laser therapy for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. Journal of the American Academy of Dermatology 27(4): 526-530, 1992

Cutaneous cryptococcosis and Kaposi's sarcoma occurring in the same lesions in a patient with the acquired immunodeficiency syndrome. Clinical and Experimental Dermatology 20(6): 480-486, 1995

Granulomas in acquired immunodeficiency syndrome-associated cutaneous Kaposi sarcoma: evidence for a role for Mycobacterium tuberculosis. Journal of Cutaneous Pathology 37(8): 827-834, 2010

Linear cutaneous lesions of Kaposi's sarcoma: a clinical clue to the diagnosis of acquired immunodeficiency syndrome. Archives of Dermatology 124(3): 327-329, 1988

Simultaneous occurrence of Kaposi's sarcoma and Cryptococcus within a cutaneous lesion in a patient with acquired immunodeficiency syndrome. Archives of Dermatology 126(5): 683-684, 1990

Lymphadenopathic form of Kaposi's sarcoma (KS) in an African child. No evidence for acquired immunodeficiency syndrome (AIDS). Helvetica Paediatrica Acta 40(6): 481-484, 1985

Cutaneous and lymphadenopathic Kaposi's sarcoma in Africa and the USA with observations on persistent lymphadenopathy in homosexual men at risk for the acquired immunodeficiency syndrome. Frontiers of Radiation Therapy and Oncology 19: 105-116, 1985

Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials. Archives of Dermatology 136(12): 1461-1469, 2000

Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. A clinical trial to evaluate efficacy and discomfort associated with infection. Journal of the American Academy of Dermatology 28(1): 61-65, 1993

Kaposi's disease and HIV negative acquired immunodeficiency syndrome (AIDS). Annales de Medecine Interne 142(6): 459-461, 1991